Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...

Three recipients were recognized for research exemplifying the core tenets of Monarch – performance, sustainability and value ...

Eli Lilly’s LLY recent announcement to acquire Verve Therapeutics, Inc VERV, a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease, has put the spotlight on ...

Amid a challenging gene editing climate, partnerships between researchers, regulators, and industry remain crucial for ...

Japanese researchers have successfully eliminated the extra chromosome responsible for Down syndrome using CRISPR gene ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

Researchers from Tel Aviv University have developed a genetic editing method tailored to crop plants, which has influenced ...

A newly discovered bacterial defense protein named Cat1 reveals an extraordinary method of viral neutralization. All living ...

Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston ...